Learn More
Medchemexpress LLC p-Tolylmaleimide | 1631-28-3 | 98.0% | 100 MG

Supplier: Medchemexpress LLC HY129592100MG
p-Tolylmaleimide (compound 9) is a naphthalimide derivative with cytotoxic effects on cancer cells. It can arrest the cell cycle of human acute myeloid leukemia cells K562 in the sub-G0/G1 phase and induce apoptosis.
- Inhibits human acute myeloid leukemia cell K562 with IC50s of 24.99 μM (24 h), 6.61 μM (48 h), and 12.10 μM (72 h).
- Inhibits human acute myeloid leukemia cell Jurkat with IC50s of 27.16 μM (24 h), 15.51 μM (48 h), and 3.94 μM (72 h).
- Cytotoxicity against human MCF7, NCI-H460, and SF-268 cells (GI50 > 10 μg/mL).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.